Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc. (Nasdaq: HSAQ) is a healthcare-focused special purpose acquisition company that completed its initial public offering in 2021, sponsored by Health Sciences Acquisitions Partners 2, LLC. The SPAC targeted the life sciences and medical technology sector, pursuing a business combination with Orchestra BioMed, Inc., a developer of minimally invasive bioelectronic and cardiovascular therapies. The company filed a Form 10-Q with the Securities and Exchange Commission on November 14, 2022, covering quarterly financial results during the period preceding the anticipated close of its announced merger. To access full deal timelines, filing history, and merger status data for HSAQ and hundreds of other SPACs, sign up for SpacDesk at spacdesk.com.